Connection

ADEL K EL-NAGGAR to Heterozygote

This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Heterozygote.
Connection Strength

0.225
  1. Mammary tumor modifiers in BALB/cJ mice heterozygous for p53. Mamm Genome. 2007 May; 18(5):300-9.
    View in: PubMed
    Score: 0.057
  2. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene. 1999 Nov 25; 18(50):7063-9.
    View in: PubMed
    Score: 0.034
  3. Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. Hum Pathol. 1997 Jun; 28(6):693-7.
    View in: PubMed
    Score: 0.028
  4. Genotypic alterations in benign and malignant salivary gland tumors: histogenetic and clinical implications. Am J Surg Pathol. 1997 Jun; 21(6):691-7.
    View in: PubMed
    Score: 0.028
  5. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance. Am J Pathol. 1996 Aug; 149(2):613-20.
    View in: PubMed
    Score: 0.027
  6. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms. Diagn Mol Pathol. 1993 Dec; 2(4):269-76.
    View in: PubMed
    Score: 0.022
  7. Polymerase chain reaction-based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma. Cancer. 1993 Aug 01; 72(3):881-6.
    View in: PubMed
    Score: 0.022
  8. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene. 1995 Jul 06; 11(1):175-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.